SAN DIEGO and WOODLAND PARK, N.J., July 29, 2015 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Cytec Industries Inc. (NYSE: CYT) by Solvay SA (EN Brussels: SOLB). On July 29, 2015, the two companies announced the signing of a definitive merger agreement pursuant to which Solvay will acquire Cytec. Under the terms of the agreement, Cytec shareholders will receive $75.25 for each share of Cytec common stock.
View this information on the law firm's Shareholder Rights Blog: www.robbinsarroyo.com/shareholders-rights-blog/cytec-industries-inc
Is the Proposed Acquisition Best for Cytec and Its Shareholders?
Robbins Arroyo LLP's investigation focuses on whether the board of directors at Cytec is undertaking a fair process to obtain maximum value and adequately compensate its shareholders.
The $75.25 merger consideration represents a premium of only 23.9% based on Cytec's closing price on June 29, 2015. This premium is significantly below the average one-month premium of nearly 32% for comparable transactions within the past five years.
Cytec shareholders have the option to file a class action lawsuit to ensure the board of directors obtains the best possible price for shareholders and the disclosure of material information. Cytec shareholders interested in information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, firstname.lastname@example.org, or via the shareholder information form on the firm's website.
Robbins Arroyo LLP is a nationally recognized leader in securities litigation and shareholder rights law. The law firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.
Attorney Advertising. Past results do not guarantee a similar outcome.
SOURCE Robbins Arroyo LLP